Single Cycle Replicating Adenovirus Vectors for Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current adenovirus vector technologies face limitations in inducing effective immune responses and treating cancer, particularly in delivering antigens and therapeutic polypeptides, as they often require integration into the host genome and have limitations in replicating and spreading within cells.
Innovation Solution
Development of single cycle replicating adenoviruses that lack specific sequences encoding proteins like fiber or V, allowing for targeted delivery of nucleic acids encoding antigens or therapeutic polypeptides, which can induce immune responses and treat cancer by infecting cells without integrating into the host genome, using cell lines to supply missing proteins for virus production and propagation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adenovirus vectors are used to deliver antigens and therapeutic polypeptides, then immune response induction and cancer treatment efficacy are improved, but the vectors require integration into the host genome and have limitations in replicating and spreading within cells
Solution Approach 1:
The adenovirus vector is segmented into two components: a replication-defective vector that delivers the antigen gene and a helper virus that provides replication functions. This segmentation allows the main vector to focus on safe antigen delivery while the helper virus enables controlled replication and spread, resolving the contradiction between reliability of immune response and adaptability of replication capability
Solution Approach 2:
A helper virus acts as an intermediary that provides the missing replication functions to the replication-defective adenovirus vector. This intermediary enables the vector to replicate and spread effectively without the vector itself containing all replication genes, thus improving adaptability while maintaining the safety and reliability of the primary delivery system
2Productivity
If adenovirus vectors replicate and spread within cells, then delivery efficiency is improved, but uncontrolled infections may occur
Solution Approach 1:
The replication capability of the adenovirus vector is made dynamic and conditional through the use of a helper virus. The vector can replicate efficiently when the helper virus is present (high productivity), but cannot replicate without it (preventing uncontrolled infection). This dynamic control resolves the contradiction between delivery efficiency and safety from uncontrolled infection
Solution Approach 2:
The system incorporates built-in safety mechanisms beforehand by using a replication-defective vector design. The vector is engineered to lack essential replication genes, which cushions against uncontrolled infection risk. The helper virus is provided in controlled amounts to enable sufficient replication for delivery efficiency while preventing excessive spread
Data Source
AI summary
This document relates to adenovirus vectors and methods and materials related to using adenovirus vectors. For example, viruses, nucleic acid molecules encoding viruses, cell lines containing viral vectors, and methods for using viruses to deliver nucleic acid to cells in vitro or in vivo are provided. Methods and materials for using adenovirus vectors to induce immune responses and to treat cancer also are provided.